Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research.
Saved in:
| Title: | Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research. |
|---|---|
| Authors: | Hurwitz LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Agalliu I; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Barry KH; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Program in Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Cheng I; Department of Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Genkinger JM; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Huang J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Joshu CE; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Key TJ; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Knutsen S; School of Public Health, Loma Linda University, Loma Linda, CA, USA., Koutros S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Langseth H; Department of Research, Cancer Registry of Norway, Oslo, Norway.; Department of Epidemiology and Biostatistics, Imperial College London, London, UK., Li SX; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC, Australia.; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK., MacInnis RJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, VIC, Australia., Markt SC; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA., Penney KL; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Perez-Cornago A; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Rohan TE; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Smith-Warner SA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Stampfer MJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Stopsack KH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tangen CM; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Weinstein SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Lang PhD W; Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA., Jacobs EJ; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA., Mucci LA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Platz EA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Cook MB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. |
| Corporate Authors: | Prostate Cancer Cohort Consortium (PC3) Working Group |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jun 01; Vol. 113 (6), pp. 727-734. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djaa154 |
